DUBLIN--(BUSINESS WIRE)--The "Pharmacovigilance" conference has been added to ResearchAndMarkets.com's offering.
This course aims to provide basic training for those concerned with pharmacovigilance.
New entrants as well as experienced operators in drug safety monitoring will benefit from the mixture of scientific knowledge and practical guidance. In addition, detailed information will be provided on regulatory developments, pharmaceutical physicians and drug safety officers. It will also be of direct benefit to all those who are involved and interested in the daily practice of pharmacovigilance.
Agenda
Day One
- Registration and Coffee
- Principles of Pharmacovigilance and Data Resources
- Risk Management and Risk Minimisation: Basic Principles
- Causality Assessment: Clinical Diagnosis of Adverse Events
- The Current Regulatory Framework and its Global Impact
- European Post-Marketing Pharmacovigilance Regulations
- Overview of Requirements
- Pro-Active Pharmacovigilance Pre-and Post Marketing
- Risk/Benefit Assessment
- Clinical: Trial ADR Reporting Requirements
- Pharmacoepidemiology Studies - Basic Designs, Strenghts, Weaknesses and Examples
- Where are We Now with PSURs (or PBRERs)
- Drug Surveillance in Countries Outside Europe
- Practicalities of Signal Detection
- Examples of Pharmacoepidemiological Studies Used in Risk Management
- Practicalities of Risk Management
- Practical Pharmacovigilance Workshop
For more information about this conference visit https://www.researchandmarkets.com/research/624fvg/3day_course_on?w=4
